8-K: Biote Corp. Announces Results of 2024 Annual Stockholders Meeting

Biote Corp. held its 2024 annual meeting of stockholders, electing three Class II directors and ratifying the appointment of Deloitte & Touche LLP as its independent auditor.

Summary

• Biote Corp. conducted its 2024 annual meeting of stockholders on May 21, 2024.
• The stockholders elected Steven J. Heyer, S. Mark Cone, and Debra L. Morris as Class II directors, each to serve until the 2027 annual meeting.
• The appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified by the stockholders.

Sentiment

Score: 7

Explanation: The document reflects standard corporate governance procedures, with no significant positive or negative surprises. The sentiment is neutral to slightly positive due to the successful election of directors and ratification of the auditor.

Positives

• All proposed directors were successfully elected to the board.
• The appointment of the independent auditor was ratified with a strong majority vote.

Industry Context

This is a standard corporate governance procedure for publicly traded companies, ensuring accountability and oversight through shareholder voting.

Comparison to Industry Standards

• The election of directors and ratification of auditors are standard practices for publicly listed companies like Biote Corp.
• The voting results are typical for such meetings, with the majority of votes cast in favor of the board's recommendations.
• Companies such as AbbVie, Amgen, and Regeneron also conduct similar annual meetings to elect directors and ratify auditors.

Stakeholder Impact

• Shareholders have exercised their voting rights to elect directors and ratify the auditor.
• The successful election of directors ensures continuity of board oversight.

Key Dates

Keywords

Annual Meeting, Board of Directors, Director Election, Independent Auditor, Deloitte & Touche, Stockholders, Corporate Governance